Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Practical and analytic issues in the electronic assessment of adherence.

Cook P, Schmiege S, McClean M, Aagaard L, Kahook M.

West J Nurs Res. 2012 Aug;34(5):598-620. doi: 10.1177/0193945911427153. Epub 2011 Nov 18.

PMID:
22101392
2.

Adherence to warfarin assessed by electronic pill caps, clinician assessment, and patient reports: results from the IN-RANGE study.

Parker CS, Chen Z, Price M, Gross R, Metlay JP, Christie JD, Brensinger CM, Newcomb CW, Samaha FF, Kimmel SE.

J Gen Intern Med. 2007 Sep;22(9):1254-9. Epub 2007 Jun 22.

3.

Barriers to use of electronic adherence monitoring in an HIV clinic.

Wendel CS, Mohler MJ, Kroesen K, Ampel NM, Gifford AL, Coons SJ.

Ann Pharmacother. 2001 Sep;35(9):1010-5.

PMID:
11573846
4.

Assessment of adherence to HIV protease inhibitors: comparison and combination of various methods, including MEMS (electronic monitoring), patient and nurse report, and therapeutic drug monitoring.

Hugen PW, Langebeek N, Burger DM, Zomer B, van Leusen R, Schuurman R, Koopmans PP, Hekster YA.

J Acquir Immune Defic Syndr. 2002 Jul 1;30(3):324-34.

PMID:
12131570
5.

Pharmacists' interventions using an electronic medication-event monitoring device's adherence data versus pill counts.

Matsuyama JR, Mason BJ, Jue SG.

Ann Pharmacother. 1993 Jul-Aug;27(7-8):851-5.

PMID:
8364262
6.

Patients' perceptions of electronic monitoring devices affect medication adherence in hypertensive African Americans.

Schoenthaler A, Ogedegbe G.

Ann Pharmacother. 2008 May;42(5):647-52. doi: 10.1345/aph.1K640. Epub 2008 Apr 8.

PMID:
18397971
7.

Assessing medication adherence by pill count and electronic monitoring in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study.

Lee JY, Kusek JW, Greene PG, Bernhard S, Norris K, Smith D, Wilkening B, Wright JT Jr.

Am J Hypertens. 1996 Aug;9(8):719-25.

PMID:
8862216
8.

Measurement of anticonvulsant adherence behaviour in the community using a Medication Events Monitoring System (MEMS)

Rivers PH, Ardagh-Walter N, Wright EC.

Health Care Anal. 1998 Dec;6(4):308-16.

PMID:
10345937
9.

Correlation between adherence rates measured by MEMS and self-reported questionnaires: a meta-analysis.

Shi L, Liu J, Fonseca V, Walker P, Kalsekar A, Pawaskar M.

Health Qual Life Outcomes. 2010 Sep 13;8:99. doi: 10.1186/1477-7525-8-99. Review.

10.

The utility of an electronic adherence assessment device in type 2 diabetes mellitus: a pilot study of single medication.

Kheir N, Greer W, Yousif A, Al-Geed H, Okkah RA, Zirie M, Sandridge A, Zaidan M.

Patient Prefer Adherence. 2010 Jul 21;4:247-54.

11.

Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring.

Waterhouse DM, Calzone KA, Mele C, Brenner DE.

J Clin Oncol. 1993 Jun;11(6):1189-97.

PMID:
8501505
12.

Optimal recall period in assessing the adherence to antihypertensive therapy: a pilot study.

Doró P, Benko R, Czakó A, Matuz M, Thurzó F, Soós G.

Int J Clin Pharm. 2011 Aug;33(4):690-5. doi: 10.1007/s11096-011-9529-7. Epub 2011 Jun 21.

PMID:
21691882
14.

Measurement of continuous ambulatory peritoneal dialysis prescription adherence using a novel approach.

Sevick MA, Levine DW, Burkart JM, Rocco MV, Keith J, Cohen SJ.

Perit Dial Int. 1999 Jan-Feb;19(1):23-30.

15.

Identifying youth nonadherence in clinical settings: data-based recommendations for children and adolescents with inflammatory bowel disease.

Greenley RN, Kunz JH, Biank V, Martinez A, Miranda A, Noe J, Telega G, Tipnis NA, Werlin S, Stephens MC.

Inflamm Bowel Dis. 2012 Jul;18(7):1254-9. doi: 10.1002/ibd.21859. Epub 2011 Aug 29.

PMID:
22689633
16.

Electronic monitoring and counseling to improve medication adherence.

Rosen MI, Rigsby MO, Salahi JT, Ryan CE, Cramer JA.

Behav Res Ther. 2004 Apr;42(4):409-22.

PMID:
14998735
17.

Electronic monitoring of adherence to treatment in the preventive chemotherapy of tuberculosis.

Fallab-Stubi CL, Zellweger JP, Sauty A, Uldry C, Iorillo D, Burnier M.

Int J Tuberc Lung Dis. 1998 Jul;2(7):525-30.

PMID:
9661817
18.

Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in Botswana.

Vriesendorp R, Cohen A, Kristanto P, Vrijens B, Rakesh P, Anand B, Iwebor HU, Stiekema J.

Eur J Clin Pharmacol. 2007 Dec;63(12):1115-21. Epub 2007 Sep 20.

19.

Cost effectiveness of an adherence-improving programme in hypertensive patients.

Brunenberg DE, Wetzels GE, Nelemans PJ, Dirksen CD, Severens JL, Stoffers HE, Schouten JS, Prins MH, de Leeuw PW, Joore MA.

Pharmacoeconomics. 2007;25(3):239-51.

PMID:
17335309
20.

Analgesic adherence measurement in cancer patients: comparison between electronic monitoring and diary.

Oldenmenger WH, Echteld MA, de Wit R, Sillevis Smitt PA, Stronks DL, Stoter G, van der Rijt CC.

J Pain Symptom Manage. 2007 Dec;34(6):639-47. Epub 2007 Aug 20.

PMID:
17703909
Items per page

Supplemental Content

Write to the Help Desk